Amadeus Capital Partners | Activity

Essay

James Baker's Capitalise #24 newsletter explores disinformation as a national security threat, the UK's new National Centre for Information Defence, and how counter-disinformation is following cybersecurity's trajectory to become a board-level concern. Features Refute's platform for detecting and disrupting hostile information campaigns.

Capitalise #24 – Trust is a currency

Amadeus Capital Partners

amadeuscapital.comOCT 2, 2026

OCT 2, 2026

Investment

Amadeus led a €15m seed round in iPremom, a molecular diagnostics company using cfRNA blood tests for first-trimester prediction of pregnancy complications, with participation from Asabys Partners and APEX Ventures.

iPremom

iPremom Amadeus Capital Partners

amadeuscapital.comSEP 2, 2026

SEP 2, 2026

Team Change

Former OrganOx CEO Craig Marshall joined Amadeus Capital Partners as a Venture Partner to support deep-tech founders.

Craig Marshall joined as Venture Partner

Amadeus Capital Partners

amadeuscapital.comJUN 2, 2026

JUN 2, 2026

Investment

Participated in Slamcore's $14M round to scale visual AI for tracking industrial vehicles.

Slamcore

Slamcore Amadeus Capital Partners

ipgroupplc.comMAY 2026

MAY 2026

Investment

Led Stateful Robotics' $4.8M pre-seed round to build long-horizon memory for physical AI/robotics.

Stateful Robotics

Stateful Robotics Amadeus Capital Partners

amadeuscapital.comMAR 24, 2026

MAR 24, 2026

Investment

Co-led enclaive's €4.1M seed round via the Amadeus APEX Technology Fund for confidential computing.

enclaive

enclaive Amadeus Capital Partners

enclaive.ioFEB 3, 2026

FEB 3, 2026

Investment

Led Refute's £5M seed round for its AI-powered counter-disinformation platform.

Refute

Refute Amadeus Capital Partners

amadeuscapital.comFEB 3, 2026 nssif.gov.uk

FEB 3, 2026

Essay

Edward Norton's blog post explains why Photonic's silicon spin qubit platform with telecom-band photon connectivity is one of the most credible paths to scalable quantum computing, covering its DARPA Quantum Benchmarking Initiative selection and $180m CAD first close.

Five reasons Photonic's quantum architecture stands apart

Amadeus Capital Partners

amadeuscapital.comJAN 8, 2026

JAN 8, 2026

Investment

Participated as an existing investor in Nu Quantum's $60M Series A, the largest quantum-networking financing round to date.

Nu Quantum

Nu Quantum Amadeus Capital Partners

amadeuscapital.comDEC 10, 2025

DEC 10, 2025

Exit

Portfolio company OrganOx was acquired by Terumo for $1.5B, one of the largest UK medtech exits on record.

OrganOx

OrganOx Amadeus Capital Partners

amadeuscapital.comAUG 2025

AUG 2025

Investment

Led Pimloc's $5M growth investment to scale its AI video-privacy and redaction platform globally.

Pimloc

Pimloc Amadeus Capital Partners

amadeuscapital.comJUL 7, 2025

JUL 7, 2025

Amadeus Capital Partners Activity

Amadeus participated in iPronics' $125m Series B co-led by Maverick Silicon and Light Street Capital (with NVIDIA joining), for silicon photonics-based optical circuit switching for AI data centers.

Amadeus led a €15m seed round in iPremom, a molecular diagnostics company using cfRNA blood tests for first-trimester prediction of pregnancy complications, with participation from Asabys Partners and APEX Ventures.

Former OrganOx CEO Craig Marshall joined Amadeus Capital Partners as a Venture Partner to support deep-tech founders.

Participated in Slamcore's $14M round to scale visual AI for tracking industrial vehicles.

Led Stateful Robotics' $4.8M pre-seed round to build long-horizon memory for physical AI/robotics.

Co-led enclaive's €4.1M seed round via the Amadeus APEX Technology Fund for confidential computing.

Led Refute's £5M seed round for its AI-powered counter-disinformation platform.

Edward Norton's blog post explains why Photonic's silicon spin qubit platform with telecom-band photon connectivity is one of the most credible paths to scalable quantum computing, covering its DARPA Quantum Benchmarking Initiative selection and $180m CAD first close.

Participated as an existing investor in Nu Quantum's $60M Series A, the largest quantum-networking financing round to date.

Portfolio company OrganOx was acquired by Terumo for $1.5B, one of the largest UK medtech exits on record.

Led Pimloc's $5M growth investment to scale its AI video-privacy and redaction platform globally.